SEC 13F Intelligence

Swiss National Bank / ABT

Swiss National Bank’s Abbott Laboratories Position

Does Swiss National Bank own Abbott Laboratories (ABT)? Yes — 5.10M shares worth $524M (+0.30% of its 13F portfolio) as of Q1 2026, up from 4.77M shares the prior filed quarter.

Position Value
$524M
Q1 2026
Shares
5.10M
% of Portfolio
+0.30%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $428MQ4 ’18Q1 ’19: $486MQ2 ’19: $500MQ3 ’19: $504MQ4 ’19: $502MQ4 ’19Q1 ’20: $560MQ2 ’20: $658MQ3 ’20: $774MQ4 ’20: $757MQ4 ’20Q1 ’21: $844MQ2 ’21: $837MQ3 ’21: $830MQ4 ’21: $948MQ4 ’21Q1 ’22: $907MQ2 ’22: $831MQ3 ’22: $734MQ4 ’22: $781MQ4 ’22Q1 ’23: $701MQ2 ’23: $684MQ3 ’23: $542MQ4 ’23: $597MQ4 ’23Q1 ’24: $591MQ2 ’24: $534MQ3 ’24: $589MQ4 ’24: $556MQ4 ’24Q1 ’25: $649MQ2 ’25: $714MQ3 ’25: $672MQ4 ’25: $598MQ4 ’25Q1 ’26: $524Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20265.10M$524M+0.30%
Q4 20254.77M$598M+0.36%
Q3 20255.02M$672M+0.39%
Q2 20255.25M$714M+0.43%
Q1 20254.89M$649M+0.46%
Q4 20244.92M$556M+0.37%
Q3 20245.16M$589M+0.38%
Q2 20245.14M$534M+0.37%
Q1 20245.20M$591M+0.41%
Q4 20235.43M$597M+0.44%
Q3 20235.59M$542M+0.42%
Q2 20236.28M$684M+0.46%
Q1 20236.92M$701M+0.48%
Q4 20227.12M$781M+0.56%
Q3 20227.59M$734M+0.53%
Q2 20227.65M$831M+0.56%
Q1 20227.66M$907M+0.51%
Q4 20216.74M$948M+0.57%
Q3 20217.03M$830M+0.53%
Q2 20217.22M$837M+0.52%
Q1 20217.05M$844M+0.56%
Q4 20206.91M$757M+0.54%
Q3 20207.11M$774M+0.60%
Q2 20207.20M$658M+0.56%
Q1 20207.10M$560M+0.59%
Q4 20195.78M$502M+0.51%
Q3 20196.03M$504M+0.54%
Q2 20195.94M$500M+0.54%
Q1 20196.08M$486M+0.53%
Q4 20185.92M$428M+0.55%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Swiss National Bank’s full portfolio or all institutional holders of ABT.